Activist 13D/13G Filings - Eliem Therapeutics Inc. (ELYM)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2024-06-06
4:16 pm
Purchase
13DEliem Therapeutics Inc.
ELYM
RA CAPITAL MANAGEMENT L.P.13,190,849
44.3%
557increase
(+0.00%)
View
2024-05-17
4:18 pm
Purchase
13DEliem Therapeutics Inc.
ELYM
RA CAPITAL MANAGEMENT L.P.13,190,292
45.3%
556increase
(+0.00%)
View
2024-05-17
4:01 pm
Unchanged
13DEliem Therapeutics Inc.
ELYM
AI ETI LLC5,009,400
17.2%
0
(Unchanged)
View
2024-05-07
6:01 pm
Purchase
13GEliem Therapeutics Inc.
ELYM
Affinity Asset Advisors LLC1,670,000
6.02%
1,670,000increase
(New Position)
View
2024-04-12
6:52 pm
Purchase
13DEliem Therapeutics Inc.
ELYM
RA CAPITAL MANAGEMENT L.P.13,189,736
47.5%
10,555increase
(+0.08%)
View
2024-03-18
4:46 pm
Purchase
13DEliem Therapeutics Inc.
ELYM
RA CAPITAL MANAGEMENT L.P.13,179,181
47.5%
2,778increase
(+0.02%)
View
2024-02-07
11:53 am
Purchase
13GEliem Therapeutics Inc.
ELYM
BML Investment Partners L.P.2,350,682
8.5%
453,068increase
(+23.88%)
View
2023-11-17
4:30 pm
Purchase
13DEliem Therapeutics Inc.
ELYM
RA CAPITAL MANAGEMENT L.P.13,176,403
47.7%
13,332increase
(+0.10%)
View
2023-11-13
5:13 pm
Unchanged
13DEliem Therapeutics Inc.
ELYM
AI ETI LLC5,009,400
18.5%
0
(Unchanged)
View
2023-04-10
5:01 pm
Purchase
13DEliem Therapeutics Inc.
ELYM
RA CAPITAL MANAGEMENT L.P.13,163,071
48.8%
11,112increase
(+0.08%)
View
2023-03-08
4:00 pm
Purchase
13GEliem Therapeutics Inc.
ELYM
Intermediate Capital Group plc2,002,563
7.5%
2,002,563increase
(New Position)
View
2023-02-14
2:22 pm
Sale
13GEliem Therapeutics Inc.
ELYM
SAMLYN CAPITAL LLC0
0%
-2,128,202decrease
(Position Closed)
View
2023-02-08
4:35 pm
Purchase
13GEliem Therapeutics Inc.
ELYM
BML Investment Partners L.P.1,897,614
7.1%
158,236increase
(+9.10%)
View
2022-09-22
5:02 pm
Purchase
13GEliem Therapeutics Inc.
ELYM
ICG Life Sciences SCSp2,002,563
7.5%
2,002,563increase
(New Position)
View
2022-05-04
11:25 am
Purchase
13GEliem Therapeutics Inc.
ELYM
BML Investment Partners L.P.1,739,378
6.5%
1,739,378increase
(New Position)
View
2022-04-04
5:12 pm
Purchase
13GEliem Therapeutics Inc.
ELYM
SAMLYN CAPITAL LLC2,128,202
8%
424,656increase
(+24.93%)
View
2022-02-14
1:42 pm
Purchase
13GEliem Therapeutics Inc.
ELYM
SAMLYN CAPITAL LLC1,703,546
6.4%
1,703,546increase
(New Position)
View
2021-08-23
3:52 pm
Purchase
13DEliem Therapeutics Inc.
ELYM
AI ETI LLC5,009,400
19.8%
5,009,400increase
(New Position)
View
2021-08-19
4:30 pm
Purchase
13DEliem Therapeutics Inc.
ELYM
RA CAPITAL MANAGEMENT L.P.13,151,959
50%
13,151,959increase
(New Position)
View